Effects of intra-arterial urokinase on a non-human primate thromboembolic stroke model

Journal of Pharmacological Sciences

Volumn 100, Issue 4, 2006, Pages 278-284

  Susumu, Teruo ^a   Yoshikawa, Tetsuya ^a   Akiyoshi, Yuki ^a   Nagata, Ryoichi ^a   Fujiwara, Michihiro ^b   Kito, Go ^a  

^a SHIN NIPPON BIOMEDICAL LABORATORIES LTD   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

Author keywords

Cynomolgus monkey; Experimental thromboembolic stroke; Neurologic deficit score; Urokinase

Indexed keywords

SODIUM CHLORIDE; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CATHETER; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD CLOT; BRAIN INFARCTION; CONSCIOUSNESS; COORDINATION; DISEASE MODEL; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; HEMISPHERE; INTERNAL CAROTID ARTERY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MONKEY; MOTOR SYSTEM; NONHUMAN; PRIMATE; SENSORY SYSTEM; SKELETAL MUSCLE; STATISTICAL SIGNIFICANCE; STROKE; THROMBOEMBOLISM;

EID: 33645861944     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0050872     Document Type: Article

References (31)

1. Zeumer H, Hacke W, Ringelstein EB. Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease. AJNR Am J Neuroradiol. 1983;4:401-404.
2. Gönner F, Remonda L, Mattle H, Sturzenegger M, Ozdoba C, Lovblad K-O, et al. Local intra-arterial thrombolysis in acute ischemic stroke. Stroke. 1998;29:1894-1900.
3. Suarez JI, Sunshine JL, Tarr R, Zaidat O, Selman WR, Kernich C, et al. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke. 1999;30:2094-2100.
4. Lee DH, Jo KD, Hyeon GK, Soo-Jung C, Seung MJ, Dae SR, et al. Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: A Pilot Study. J Vasc Interv Radiol. 2002;13:769-773.
5. Jahan R, Duckwiler GR, Kidwell CS, Sayre JW, Gobin YP, PabloVillablanca J, et al. Intraarterial thrombolysis for treatment of acute stroke: Experience in 26 patients with long-term follow-up. AJNR Am J Neuroradiol. 1999;20:1291-1299.
6. Keris V, Rudnicka S, Vorona V, Enina G, Tilgale B, Fricbergs J. Combined intraarterial/intravenous thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol. 2001;22:352-358.
7. Barnwell SL, Clark WM, Nguyen TT, O'Neill OR, Wynn ML, Coull BM. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR Am J Neuroradiol. 1994;15:1817-1822.
8. Ng PP, Higashida RT, Cullen SP, Malek R, Dowd CF, Halbach VV. Intraarterial thrombolysis trials in acute ischemic stroke. J Vasc Interv Radiol. 2004;15:S77-S85.
9. No authors listed. Special report from National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular disorders III. Stroke. 1990;21:637-676.
10. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population - based study of incidence and risk factors. Stroke. 1999;30:2513-2516.
11. Schellinger PD, Fiebach JB, Mohr A, Ringleb PA, Jansen O, Hacke W. Thrombolytic therapy for ischemic stroke - a review. Part I - Intravenous thrombolysis. Crit Care Med. 2001;29:1812-1818.
12. Schellinger PD, Fiebach JB, Mohr A, Ringleb PA, Jansen O, Hacke W. Thrombolytic therapy for ischemic stroke - A review. Part II - Intra-arterial thrombolysis, vertebrobasilar stroke, phase IV trials, and stroke imaging. Crit Care Med. 2001;29:1819-1825.
13. Ginsberg MD, Busto R. Rodent models of cerebral ischemia. Stroke. 1989;20:1627-1642.
14. Nagasawa H, Kogure K. Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke. 1989;20:1037-1043.
15. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20:84-91.
16. Hegedus K, Fekete I, Tury F, Molnar L. Experimental focal cerebral ischaemia in rabbits. J Neurol. 1985;232:223-230.
17. Miyabe M, Mori S, van Zijl PCM, Kirsch JR, Eleff SM, Koehler RC, et al. Correlation of the average water diffusion constant with cerebral blood flow and ischemic damage after transient middle cerebral artery occlusion in cats. J Cereb Blood Flow Metab. 1996;16:881-891.
18. Gillian L. The arterial and venous blood supplies to the forebrain (including internal capsule) of primates. Neurology. 1968;18:653-670.
19. Crowell RM, Marcoux FW, DeGirolami U. Variability and reversibility of focal cerebral ischemia in unanesthetized monkeys. Neurology. 1981;31:1295-1302.
20. Kitamura Y, Takata K, Inden M, Tsuchiya D, Yanagisawa D, Nakata J, et al. Intracerebroventricular injection of microglia protects against focal brain ischemia. J Pharmacol Sci. 2004;94:203-206.
21. Ringer AJ, Guterman LR, Hopkins LN. Site-specific thromboembolism: A novel animal model for stroke. AJNR Am J Neuroradiol. 2004;25:329-332.
22. Kito G, Nishimura A, Susumu T, Nagata R, Kuge Y, Yokota C, et al. Experimental thromboembolic stroke in cynomolgus monkey. J Neurosci Methods. 2001;105:45-53.
23. Dettmers C, Hartmann A, Rommel T, Kramer S, Pappata S, Young A, et al. Immersion and perfusion staining with 2,3,5-triphenyltetrazolium chloride (TTC) compared to mitochondrial enzymes 6 hours after MCA-occlusion in primates. Neurol Res. 1994;16:205-208.
24. Dettmers C, Hartmann A, Rommel T, Hartmann S, Pappata S, Baron JC. Contralateral cerebellar diaschisis 7 hours after MCA-occlusion in primates. Neurol Res. 1995;17:109-112.
25. Kuge Y, Yokota C, Tagaya M, Hasegawa Y, Nishimura A, Kito G, et al. Serial changes in cerebral blood flow - metabolism uncoupling in primates with acute thromboembolic stroke. J Cereb Blood Flow Metab. 2001;21:202-210.
26. Del Zoppo GJ, Copeland BR, Waltz TA, Zyroff J, Plow EF, Harker LA. The beneficial effect of intracarotid urokinase on acute stroke in a baboon model. Stroke. 1986;17:638-643.
27. Shuaib A, Yang Y, Li Q, Siddiqui MM, Kalar J. Intraarterial urokinase produces significant attenuation of infarction volume in an embolic focal ischemia model. Exp Neurol. 1998;154:330-335.
28. Lo EH, Wang X, Cuzner ML. Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J Neurosci Res. 2002;69:1-9.
29. Rosenberg GA, Estrada EY, Denocoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke. 1998;29:2189-2195.
30. Mun-Bryce S, Rosenberg GA. Matrix metalloproteinases in cerebrovascular disease. J Cereb Blood Flow Metab. 1998;18:1163-1172.
31. Papadopoulos SM, Chandler WF, Salamat MS, Topol EJ, Sackellares JC. Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke. J Neurosurg. 1987;67:394-398.